Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor imidazoacridone available for licensing from BTG

Sep. 3, 1998

Protegrin analogue safe in cancer patients receiving chemotherapy

Sep. 3, 1998

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

AEterna isolates molecule exhibiting anti-MMP activity

Sep. 2, 1998

Orphan drug designation granted for thalidomide in KS

Sep. 1, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Sep. 1, 1998

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

Sep. 1, 1998

New anticancer agents discovered at American Cyanamid

Sep. 1, 1998

Prolifix and BioFocus to cooperate on cancer drug development

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...